Trevena, Inc. (TRVN) To Host Conference Call On May 9th To Discuss First Quarter 2014 Financial Results And Recent Highlights
5/2/2014 9:44:05 AM
Trevena, Inc. (NASDAQ: TRVN), a clinical stage pharmaceutical company focused on the discovery and development of G-protein coupled receptor (GPCR) biased ligands, today announced that it will host a conference call on Friday, May 9, 2014 at 11:00 a.m. Eastern Time to discuss corporate updates and financial results for the first quarter ended March 31, 2014.
Help employers find you! Check out all the jobs and post your resume.
comments powered by